Global life science company Abcam plc has been engaged to produce reagents for Proteomics International’s immunoassay version of the PromarkerD test for diabetic kidney disease.
Working with Abcam will help streamline test production, allowing Proteomics International to service anticipated demand for PromarkerD worldwide. The engagement signifies Proteomics International achieving another milestone as it continues the path towards commercialisation of PromarkerD in global markets.
